Next, we observed that AML cells treated with AraC in vivo had higher protein expression levels of CALCRL, and a slight increase in RAD51 and BCL2, whereas CHK1 was similar to untreated cells (Fig. 6f). This evidence concerns the gene RAD51 and acute myeloid leukemia.